Corcept Therapeutics, Inc. (CORT)
72.96
-0.75
(-1.02%)
USD |
NASDAQ |
Nov 13, 16:00
72.96
0.00 (0.00%)
After-Hours: 19:59
Corcept Therapeutics Total Assets (Quarterly) : 1.034B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.034B |
| June 30, 2026 | 888.70M |
| March 31, 2026 | 814.88M |
| December 31, 2025 | 838.03M |
| September 30, 2025 | 823.61M |
| June 30, 2025 | 801.72M |
| March 31, 2025 | 846.46M |
| December 31, 2024 | 840.55M |
| September 30, 2024 | 784.26M |
| June 30, 2024 | 714.56M |
| March 31, 2024 | 655.94M |
| December 31, 2023 | 621.52M |
| September 30, 2023 | 594.02M |
| June 30, 2023 | 524.62M |
| March 31, 2023 | 617.85M |
| December 31, 2022 | 583.43M |
| September 30, 2022 | 533.26M |
| June 30, 2022 | 496.36M |
| March 31, 2022 | 468.12M |
| December 31, 2021 | 423.76M |
| September 30, 2021 | 585.40M |
| June 30, 2021 | 568.48M |
| March 31, 2021 | 552.40M |
| December 31, 2020 | 571.73M |
| September 30, 2020 | 534.12M |
| Date | Value |
|---|---|
| June 30, 2020 | 497.82M |
| March 31, 2020 | 445.49M |
| December 31, 2019 | 412.31M |
| September 30, 2019 | 367.02M |
| June 30, 2019 | 328.68M |
| March 31, 2019 | 320.21M |
| December 31, 2018 | 311.69M |
| September 30, 2018 | 299.75M |
| June 30, 2018 | 274.38M |
| March 31, 2018 | 242.98M |
| December 31, 2017 | 220.54M |
| September 30, 2017 | 110.67M |
| June 30, 2017 | 86.54M |
| March 31, 2017 | 75.34M |
| December 31, 2016 | 68.75M |
| September 30, 2016 | 62.93M |
| June 30, 2016 | 56.84M |
| March 31, 2016 | 52.91M |
| December 31, 2015 | 51.94M |
| September 30, 2015 | 48.38M |
| June 30, 2015 | 48.36M |
| March 31, 2015 | 48.22M |
| December 31, 2014 | 34.63M |
| September 30, 2014 | 37.16M |
| June 30, 2014 | 44.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 204.54B |
| Phibro Animal Health Corp. | 1.515B |
| Illumina, Inc. | 6.812B |
| Eli Lilly & Co. | 148.07B |
| Merck & Co., Inc. | 132.77B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 200.29M |
| Shareholders Equity (Quarterly) | 833.74M |
| Debt to Equity Ratio | 0.0108 |
| Current Ratio | 2.971 |
| Net Debt Paydown Yield | 0.00% |